DTX-P7
DTX-P7 is a peptide-drug conjugate of Docetaxel and a heptapeptide that triggers apoptosis by inducing the unfolded protein response through Hsp90 degradation. It is utilized in cancer research for studying targeted chemotherapy mechanisms in both in vitro and in vivo experimental models.
Product Specifications
Field of Research
Cell Biology, Metabolism Research, Signal Transduction
Molecular Weight
1639.87
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog